Lung Cancer

"Performing an annual chest CT scan on people at risk helps to reduce lung cancer mortality".


The Lung Cancer Area is composed of specialists in Pneumology, Medical Oncology, Radiation Oncology, Thoracic Surgery, Radiology, Nuclear Medicine and Pathological Anatomy, as well as researchers from the Solid Tumours and Biomarkers Programme from Cima.

The diagnostic process integrates tumour molecular biology in order to achieve the most complete diagnosis possible.

The Area counts with the collaboration of CIMA LAB Diagnostics, a comprehensive genetic diagnosis unit where a detailed study of each patient's tumour is carried out, which makes it possible to determine personalised treatment for each genetic alteration. 

Another key factor of the Lung Cancer Area is its clinical and translational research, as it allows patients to participate in clinical trials with the application of new drugs for lung cancer. 

Dr. Javier Zulueta, co-director of the Area, is the principal investigator of our Centre in the I-ELCAP International Study of early diagnosis of lung cancer in population at risk, in which the Clinic is the only Spanish centre participating.

Imagen del icono de la consulta de Segunda Opinión. Clínica Universidad de Navarra

Do you need us to help you?

Contact us

Advanced diagnosis and treatment



  • Surgical treatment
  • Chemotherapy
  • Radiotherapy

Advanced treatments for better medical care


Immunotherapy for lung cancer

We have a great deal of experience in managing the most innovative therapies for the treatment of lung cancer.

Videothoracoscopic Surgery

Minimally invasive surgery by which it is possible to visualise and operate inside the chest through minimal 1-2 cm incisions in the chest wall.

Combined treatment

We seek to improve the effectiveness of immunotherapy through its use in combination with other drugs or treatments, such as chemotherapy and radiotherapy.

Do you need to request a consultation with one of our specialists?


Comprehensive patient care

The objective of the Lung Cancer Area is to offer the patient the vision and the joint and integrated work of the different specialists involved in the diagnosis and treatment of lung cancer. We work together in order to ensure the rapid resolution of your problem.

Early detection

In our annual low-dose radiation CT early detection programme, 85% of lung cancers detected are at stage I, with a high probability of cure.

Liquid biopsy

With a blood test we detect the specific genetic mutations of the tumour and establish a specific treatment that is more effective and less toxic.

Cutting-edge technology

We have the most advanced technology for the diagnosis and treatment of lung cancer. We have the Da Vinci® robot to perform, in the indicated cases, a precision approach.

Imagen de la fachada de consultas de la sede en Pamplona de la Clínica Universidad de Navarra

Why choose the Clinic?

  • Integral evaluation of the patient.
  • Possibility of starting personalised treatment 48 hours after the first consultation.
  • Minimally invasive surgery for the rapid recovery of our patients.
  • Our team of professionals.

Experience in studying the use of immunotherapy and the development of advanced therapies against lung cancer

Research into
lung cancer

The Lung Cancer Area has several clinical trials underway at different stages of the disease with the aim of achieving treatments that are more effective.

Participation in these trials provides patients with new possibilities by allowing access to the latest therapeutic advances.

We help our patients to overcome their stories

Their testimonies encourage us to continue improving our services

Safer than ever to continue taking care of you

We update safety protocols weekly with the latest scientific evidence and the knowledge of the best international centers with which we collaborate.